Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase (Q35927116)

From Wikidata
Jump to navigation Jump to search
scientific article published in April 2012
edit
Language Label Description Also known as
English
Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase
scientific article published in April 2012

    Statements

    Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase (English)
    L G Feun
    A Marini
    G Walker
    G Elgart
    F Moffat
    S E Rodgers
    M Wangpaichitr
    M T Kuo
    W Sisson
    A A Jungbluth
    J Bomalaski
    N Savaraj
    1 April 2012
    106
    1481-1485

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit